23 Sep 2025 | 5 Mins Read
InvAscent-backed firm plans Rs 1,200-crore IPO with bank talks
Flipitmoney
Malladi Drugs and Pharmaceuticals Limited, a Chennai-based active pharmaceutical ingredients (API) maker, is considering a public market debut through an initial public offering (IPO) that could raise Rs 1,000-1,200 crore. The company raised Rs 250 crore from InvAscent, its private equity investor, and holds a 22-23 percent stake. IPO discussions are in early stages.